ABSTRACT
Objective To systematically review the efficacy and safety of bevacizumab biosimilars versus original drugs in treatment of metastatic colorectal cancer.Methods PubMed,Embase,Cochrane Library,CNKI,WanFang Data,VIP and SinoMed databases were electronically searched to collect the randomized controlled trials(RCTs)of bevacizumab biosimilar in patients with metastatic colorectal cancer from inception to June 18,2023.Two reviewers independently screened the literature,extracted data,and assessed the risk of bias of the included studies,and a meta-analysis was conducted using Stata 17.0 software.Results A total of 4 RCTs involving 1 052 patients were included.The results of meta-analysis showed that no significant difference was found in overall response rate(RD=﹣0.01,95%CI ﹣0.06 to 0.05,P=0.86),progression free survival(HR=1.00,95%CI 0.91 to 1.09,P=0.94),the total incidence of adverse drug reactions(RR=1.05,95%CI 0.85 to 1.31,P=0.91)and the incidence of severe adverse events(RR=0.886,95%CI 0.377 to 2.081,P=0.60)between bevacizumab biosimilars group and original drugs group.Conclusion The current evidence shows that bevacizumab biosimilar is equivalent to original drugs in treatment of metastatic colorectal cancer.Due to limited quality and quantity of the included studies,more high quality studies are required to verify the above conclusions.
ABSTRACT
Objective The pathogenesis of orla ulcer has not been fully and thoroughly studied. This study aimed to investi-gate the effect and mechanism of Rosmarinic acid (RA)on oral ulcer. Methods 60 SD rats were randomly divided into control group,model group,RA groups(20,40,80 mg/kg) and Watermelon Frost group. The control group rats were fed normally and with-out any treatment. The oral ulcer model was established in the other three groups. The oral ulcer model of rat was established by injec-tion of 40% glacial acetic acid on the oral mucosa of cheek in rat. One day after the formation of ulcers,RA(20,40,80 mg/kg) and watermelon frost (200 mg/kg) was administrated. The ulcer area was measured 3,5,7 days after establishing the model. The concen-tration of IL-18 and IL-1β in ulcer tissue was measured by ELISA method and the expression of NLRP3 mRNA was measured by qRT-PCR. Results Compared with the model group, the ulcer area in the RA group and Watermelon Frost group was significantly de-ceased(P<0.05). Compared with the control group,NLRP3,IL-18 and IL-1β in the ulcer tissue was significantly elevated in model group,RA groups (20,40,80 mg/kg) and Watermelon Frost group (P<0.01). NLRP3 expressed lower in RA (40,80 mg/kg) and wa-termelon frost (200 mg/kg) group(5.27 ± 0.53, 3.25 ± 0.46, 4.75 ± 0.51) than in model group(8.71±0.35)( P<0.05). IL-18 expressed lower in RA (40, 80 mg/kg) and watermelon frost (200 mg/kg) group [(174.21±18.21), (110.12±14.23), (142.25±12.61) pg/mL] than in model group [(246.21±26.21) pg/mL](P<0.05). IL-1β expressed lower in RA (40, 80 mg/kg) and watermelon frost(200 mg/kg) group [(94.76±7.26),(81.77±7.80),(90.21±8.71) pg/mL] than in model group [(133.01±11.69) pg/mL](P<0.05). Conclusion RA has some therapeutic effect on oral ulcers,the mechanism may be related to NLRP3.